Healthcare Services - Home Health and Hospice Care
Strategic Profile
Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. The company is positioned in the growing home-based care market, benefiting from aging demographics and healthcare cost containment trends. The company was announced to be acquired by Kinderhook Industries for approximately $1.1 billion, with stockholders receiving $13.80 per share in cash, representing a 24.4% premium to the closing price on February 20, 2026.
Cyborg Score Rationale
Recent quarterly earnings missed analyst estimates with $0.04 EPS against $0.06 expected and revenue of $258.2M against $264.3M expected. The company operates in a structurally attractive but operationally challenging segment. The pending acquisition closing in Q2 2026 creates execution risk and uncertainty for ongoing operations.
Top Insights
Company was formerly known as Encompass Health Home Health Holdings and changed its name to Enhabit in March 2022
Announced acquisition by PE firm Kinderhook Industries at $1.1B enterprise value, implying modest valuation multiples for scale home health operator
Q1 2026 earnings miss on both EPS and revenue suggests operational headwinds or margin pressures in sector